Sutro Biopharma, Inc. (STRO) at a glance

Sutro Biopharma, Inc. (STRO) is a small-cap Healthcare company. It trades at $20.34, with a -154.2% profit margin and revenue decline of 16.5%. It does not pay a dividend. Vestovix scores it 36/100 overall. Its strongest dimension is Safety (44/100) and its weakest is Growth (21/100). It carries above-market volatility, so expect larger swings.

Price

$20.34

Market cap

$477.2M

P/E ratio

n/a

Dividend yield

None

Beta

1.55

52-week range

$7.15 to $43.85